卡瓦提取物治疗引起的皮脂溢性药物反应：一种新情况？ - Suppr

Suppr

超能文献

Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity?

作者信息

Jappe U, Franke I, Reinhold D, Gollnick H P

机构信息

Department of Dermatology and Venereology, Otto-von-Guericke-University of Magdeburg, Germany.

出版信息

J Am Acad Dermatol. 1998 Jan;38(1):104-6. doi: 10.1016/s0190-9622(98)70547-x.

DOI:10.1016/s0190-9622(98)70547-x

PMID:9448214

Abstract

摘要

相似文献

Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity?

J Am Acad Dermatol. 1998 Jan;38(1):104-6. doi: 10.1016/s0190-9622(98)70547-x.

Sebotropic eruption associated with use of oral kava kava supplement.

Clin Exp Dermatol. 2014 Oct;39(7):816-8. doi: 10.1111/ced.12439.

Acute cutaneous toxicity with kava: an inflammatory sebotropic reaction and urticaria.

Clin Exp Dermatol. 2020 Jun;45(4):527-530. doi: 10.1111/ced.14129. Epub 2019 Nov 10.

[Hematogenous contact eczema cause by phytogenic drugs exemplified by kava root extract].

Hautarzt. 1996 Jun;47(6):459-61. doi: 10.1007/s001050050451.

Coma from the health food store: interaction between kava and alprazolam.

Ann Intern Med. 1996 Dec 1;125(11):940-1. doi: 10.7326/0003-4819-125-11-199612010-00023.

Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.

Pharmacopsychiatry. 1997 Jan;30(1):1-5. doi: 10.1055/s-2007-979474.

[Sebotropic drug eruption after ingestion of bee pollen].

Ann Dermatol Venereol. 2020 Feb;147(2):135-139. doi: 10.1016/j.annder.2019.09.605. Epub 2019 Dec 9.

Kava: Piper methysticum.

Am J Health Syst Pharm. 1999 May 15;56(10):957-8, 960. doi: 10.1093/ajhp/56.10.957.

Kava: a comprehensive review of efficacy, safety, and psychopharmacology.

Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Epub 2010 Nov 15.

[Drug therapy of panic disorders. Kava-specific extract WS 1490 compared to benzodiazepines].

Nervenarzt. 1994 Jan;65(1 Suppl):1-4.

引用本文的文献

Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations.

Drug Alcohol Rev. 2025 Sep;44(6):1601-1640. doi: 10.1111/dar.14080. Epub 2025 Jun 25.

Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy.

J Med Toxicol. 2024 Jul 11;20(3):308-313. doi: 10.1007/s13181-024-01016-x. Epub 2024 Jun 5.

Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern.

JAAD Case Rep. 2018 Nov 10;4(10):1037-1038. doi: 10.1016/j.jdcr.2018.08.011. eCollection 2018 Nov.

Inflammatory sebotropic reaction associated with kava kava ingestion.

JAAD Case Rep. 2018 Apr 30;4(5):437-439. doi: 10.1016/j.jdcr.2017.12.011. eCollection 2018 Jun.

Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells.

Phytother Res. 2012 Dec;26(12):1934-41. doi: 10.1002/ptr.4652. Epub 2012 Apr 4.

A systematic review of the safety of kava extract in the treatment of anxiety.

Drug Saf. 2002;25(4):251-61. doi: 10.2165/00002018-200225040-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Sebotropic drug reaction resulting from kava-kava extract therapy: a new entity?

J Am Acad Dermatol. 1998 Jan;38(1):104-6. doi: 10.1016/s0190-9622(98)70547-x.

Sebotropic eruption associated with use of oral kava kava supplement.

Clin Exp Dermatol. 2014 Oct;39(7):816-8. doi: 10.1111/ced.12439.

Acute cutaneous toxicity with kava: an inflammatory sebotropic reaction and urticaria.

Clin Exp Dermatol. 2020 Jun;45(4):527-530. doi: 10.1111/ced.14129. Epub 2019 Nov 10.

[Hematogenous contact eczema cause by phytogenic drugs exemplified by kava root extract].

Hautarzt. 1996 Jun;47(6):459-61. doi: 10.1007/s001050050451.

Coma from the health food store: interaction between kava and alprazolam.

Ann Intern Med. 1996 Dec 1;125(11):940-1. doi: 10.7326/0003-4819-125-11-199612010-00023.

Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.

Pharmacopsychiatry. 1997 Jan;30(1):1-5. doi: 10.1055/s-2007-979474.

[Sebotropic drug eruption after ingestion of bee pollen].

Ann Dermatol Venereol. 2020 Feb;147(2):135-139. doi: 10.1016/j.annder.2019.09.605. Epub 2019 Dec 9.

Kava: Piper methysticum.

Am J Health Syst Pharm. 1999 May 15;56(10):957-8, 960. doi: 10.1093/ajhp/56.10.957.

Kava: a comprehensive review of efficacy, safety, and psychopharmacology.

Aust N Z J Psychiatry. 2011 Jan;45(1):27-35. doi: 10.3109/00048674.2010.522554. Epub 2010 Nov 15.

[Drug therapy of panic disorders. Kava-specific extract WS 1490 compared to benzodiazepines].

Nervenarzt. 1994 Jan;65(1 Suppl):1-4.

引用本文的文献

Global Perspectives on Kava: A Narrative Systematic Review of the Health Effects, Economic and Social Impacts and Policy Considerations.

Drug Alcohol Rev. 2025 Sep;44(6):1601-1640. doi: 10.1111/dar.14080. Epub 2025 Jun 25.

Neonatal and Maternal Ichthyosiform Dermopathy in Association with Kava Use during Pregnancy.

J Med Toxicol. 2024 Jul 11;20(3):308-313. doi: 10.1007/s13181-024-01016-x. Epub 2024 Jun 5.

Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern.

JAAD Case Rep. 2018 Nov 10;4(10):1037-1038. doi: 10.1016/j.jdcr.2018.08.011. eCollection 2018 Nov.

Inflammatory sebotropic reaction associated with kava kava ingestion.

JAAD Case Rep. 2018 Apr 30;4(5):437-439. doi: 10.1016/j.jdcr.2017.12.011. eCollection 2018 Jun.

Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells.

Phytother Res. 2012 Dec;26(12):1934-41. doi: 10.1002/ptr.4652. Epub 2012 Apr 4.

A systematic review of the safety of kava extract in the treatment of anxiety.

Drug Saf. 2002;25(4):251-61. doi: 10.2165/00002018-200225040-00003.